Cargando…

Racial differences in distribution of fatty acids in prostate cancer and benign prostatic tissues

BACKGROUND: It remains controversial whether and which fatty acids are different between prostate cancer (PCa) and benign prostatic tissues (BPT) in association with occurrence, progression and racial disparity between African American (AA) and Caucasian American (CA) populations. METHODS: Total fat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhou, Xinchun, Mei, Hao, Agee, Joshua, Brown, Timera, Mao, Jinghe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825718/ https://www.ncbi.nlm.nih.gov/pubmed/31677641 http://dx.doi.org/10.1186/s12944-019-1130-4

Ejemplares similares

The association of prostatic lipids with progression, racial disparity and discovery of biomarkers in prostate cancer
por: Zhou, Xinchun, et al.
Publicado: (2021)

Essential fatty acid distribution in the plasma and tissue phospholipids of patients with benign and malignant prostatic disease.
por: Chaudry, A., et al.
Publicado: (1991)

Geographic Distribution of Racial Differences in Prostate Cancer Mortality
por: Fletcher, Sean A., et al.
Publicado: (2020)

Differential Utilization of Dietary Fatty Acids in Benign and Malignant Cells of the Prostate
por: Dueregger, Andrea, et al.
Publicado: (2015)

Distribution and clinical relevance of phospholipids in hepatocellular carcinoma
por: Liu, Zhirong, et al.
Publicado: (2020)

A Retrospective Study on Pathologic Features and Racial Disparities in Prostate Cancer
por: Bigler, Steven A., et al.
Publicado: (2011)

Tissue microenvironment and benign prostatic hyperplasia
por: Wei, Xing, et al.
Publicado: (2019)

Racial Differences in the Diagnosis and Treatment of Prostate Cancer
por: Pietro, Giuliano Di, et al.
Publicado: (2016)

The effect of prostate tissue inflammation in benign prostatic hyperplasia on enhancer of zeste homolog 2 ribonucleic acid expression
por: Al-Maghrebi, May, et al.
Publicado: (2012)

Transcriptomic profiles of peripheral white blood cells in type II diabetes and racial differences in expression profiles
por: Mao, Jinghe, et al.
Publicado: (2011)

Nonalcoholic Fatty Liver Disease Is Associated with Benign Prostate Hyperplasia
por: Chung, Goh Eun, et al.
Publicado: (2020)

Studies on immunocytochemical localization of inhibin-like material in human prostatic tissue: comparison of its distribution in normal, benign and malignant prostates.
por: Doctor, V. M., et al.
Publicado: (1986)

SUN-747 Steroid Hormone Metabolism Mediated Racial Disparity in Men with Benign Prostatic Hyperplasia
por: Liu, Teresa T, et al.
Publicado: (2020)

Racial differences in the systemic inflammatory response to prostate cancer
por: Rundle, Andrew G., et al.
Publicado: (2021)

Biexponential Apparent Diffusion Coefficients Values in the Prostate: Comparison among Normal Tissue, Prostate Cancer, Benign Prostatic Hyperplasia and Prostatitis
por: Liu, Xiaohang, et al.
Publicado: (2013)

Detection of Trichomonas vaginalis in prostate tissue and serostatus in patients with asymptomatic benign prostatic hyperplasia
por: Iqbal, Jamshaid, et al.
Publicado: (2016)

Phenotype and Reactivity of Lymphocytes Expanded from Benign Prostate Hyperplasic Tissues and Prostate Cancer
por: Ahmed, Ritaparna, et al.
Publicado: (2023)

Identification of Plasma Lipid Biomarkers for Prostate Cancer by Lipidomics and Bioinformatics
por: Zhou, Xinchun, et al.
Publicado: (2012)

Benign Prostatic Hyperplasia
Publicado: (2015)

Influence of metabolic syndrome on the relationship between fatty acids and the selected parameters in men with benign prostatic hyperplasia
por: Grzesiak, Katarzyna, et al.
Publicado: (2019)

A comparison of virtual touch tissue quantification and digital rectal examination for discrimination between prostate cancer and benign prostatic hyperplasia
por: Zheng, Xiaozhi, et al.
Publicado: (2011)

Racial differences in prostate inflammation: results from the REDUCE study
por: Vidal, Adriana C., et al.
Publicado: (2016)

Relationship between Apparent Diffusion Coefficient Distribution and Cancer Grade in Prostate Cancer and Benign Prostatic Hyperplasia
por: Saito, Shigeyoshi, et al.
Publicado: (2022)

Synergistic interaction of benign prostatic hyperplasia and prostatitis on prostate cancer risk
por: Hung, S-C, et al.
Publicado: (2013)

Characterization of infiltrating lymphocytes in human benign and malignant prostate tissue
por: Rådestad, Emelie, et al.
Publicado: (2017)

Prostatitis and benign prostatic hyperplasia: emerging infectious diseases?
por: Hennenfent, B
Publicado: (1997)

Zinc status in benign prostatic hyperplasia and prostate carcinoma
por: Wiwanitkit, Somsri, et al.
Publicado: (2012)

Serum organic acid metabolites can be used as potential biomarkers to identify prostatitis, benign prostatic hyperplasia, and prostate cancer
por: He, Jinhua, et al.
Publicado: (2023)

Prostate Specific Antigen, Mean Platelet Volume, and Platelet Distribution Width in Combination to Discriminate Prostate Cancer from Benign Prostate Hyperplasia
por: Fu, Shuang, et al.
Publicado: (2018)

Biomarkers of Prostatic Cancer: An Attempt to Categorize Patients into Prostatic Carcinoma, Benign Prostatic Hyperplasia, or Prostatitis Based on Serum Prostate Specific Antigen, Prostatic Acid Phosphatase, Calcium, and Phosphorus
por: Sarwar, Shahana, et al.
Publicado: (2017)

Impact of Benign Prostatic Hyperplasia and/or Prostatitis on the Risk of Prostate Cancer in Korean Patients
por: Kim, Sung Han, et al.
Publicado: (2021)

High risk human papilloma viruses (HPVs) are present in benign prostate tissues before development of HPV associated prostate cancer
por: Glenn, Wendy K., et al.
Publicado: (2017)

Etiopathogenesis of benign prostatic hypeprlasia
por: Tang, Jie, et al.
Publicado: (2009)

Testosterone and benign prostatic hyperplasia
por: Jarvis, Thomas R, et al.
Publicado: (2015)

Transurethral Resection of Prostate Abscess: Is It Different from Conventional Transurethral Resection for Benign Prostatic Hyperplasia?
por: Goyal, Neeraj Kumar, et al.
Publicado: (2013)

Racial Differences in Immunological Landscape Modifiers Contributing to Disparity in Prostate Cancer
por: King Thomas, Jeronay, et al.
Publicado: (2019)

Racial Differences in Prostate Cancer Characteristics and Cancer-Specific Mortality: An Overview
por: Hinata, Nobuyuki, et al.
Publicado: (2022)

Seminal vesicle abnormalities following prostatic artery embolization for the treatment of benign prostatic hyperplasia
por: Zhang, Jin Long, et al.
Publicado: (2018)

Simplified Chinese version of the international prostate symptom score and the benign prostatic hyperplasia impact index: cross-cultural adaptation, reliability, and validity for patients with benign prostatic hyperplasia
por: Dun, Rong-liang, et al.
Publicado: (2022)

Immunohistochemical localization of prostate-specific antigen in benign and malignant breast tissues.
por: Howarth, D. J., et al.
Publicado: (1997)

Cannot write session to /tmp/vufind_sessions/sess_ncm07991rpqmrc09mlo5mvi29b